1048 related articles for article (PubMed ID: 18630055)
1. [Genetic evolution of poliovirus: success and difficulties in the eradication of paralytic poliomyelitis].
Blondel B; Autret A; Brisac C; Pelletier I; Martin-Latil S; Jegouic S; Bessaud M; Joffret ML; Balanant J; Colbère-Garapin F; Delpeyroux F
Med Trop (Mars); 2008 Apr; 68(2):189-202. PubMed ID: 18630055
[TBL] [Abstract][Full Text] [Related]
2. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
Minor P
Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
[TBL] [Abstract][Full Text] [Related]
3. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
[TBL] [Abstract][Full Text] [Related]
4. Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(25):846-50. PubMed ID: 21716199
[TBL] [Abstract][Full Text] [Related]
5. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
Friedrich F
Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
[TBL] [Abstract][Full Text] [Related]
6. [Worldwide eradication of poliomyelitis].
Rasch G; Schreier E; Kiehl W; Kurth R
Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
[TBL] [Abstract][Full Text] [Related]
7. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
Pliaka V; Kyriakopoulou Z; Markoulatos P
Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
[TBL] [Abstract][Full Text] [Related]
8. A case for developing antiviral drugs against polio.
Collett MS; Neyts J; Modlin JF
Antiviral Res; 2008 Sep; 79(3):179-87. PubMed ID: 18513807
[TBL] [Abstract][Full Text] [Related]
9. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
[TBL] [Abstract][Full Text] [Related]
10. Strengths and weaknesses of current polio vaccines--a view from industry.
André FE
Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
[TBL] [Abstract][Full Text] [Related]
11. Vaccination strategies for the last stages of global polio eradication.
Bompart F
Indian Pediatr; 2005 Feb; 42(2):163-9. PubMed ID: 15767713
[TBL] [Abstract][Full Text] [Related]
12. Update on vaccine-derived polioviruses.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(40):1093-7. PubMed ID: 17035927
[TBL] [Abstract][Full Text] [Related]
13. Update on vaccine-derived polioviruses--worldwide, April 2011-June 2012.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():741-6. PubMed ID: 22992572
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of poliomyelitis--options and update.
Dutta A
Vaccine; 2008 Oct; 26(45):5767-73. PubMed ID: 18755232
[TBL] [Abstract][Full Text] [Related]
15. World wide experience with inactivated poliovirus vaccine.
Bonnet MC; Dutta A
Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
[TBL] [Abstract][Full Text] [Related]
16. [End phase challenges of poliomyelitis eradication programme realization].
Jarzabek Z
Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
[TBL] [Abstract][Full Text] [Related]
17. Risks of reintroduction of polio after eradication: the vaccine origin of an outbreak of type 3 poliomyelitis.
Martin J; Ferguson GL; Wood DJ; Minor PD
Dev Biol (Basel); 2001; 105():83-92. PubMed ID: 11763341
[TBL] [Abstract][Full Text] [Related]
18. [Circulation of the poliovirus in endemic zones with children vaccinated by the oral polio vaccine].
Gouandjika I; Rakoto Andrianarivelo M; Akoua-Koffi C; Zeller H; Ehouman A; Morvan JM
Bull Soc Pathol Exot; 2000 Jul; 93(3):198-201. PubMed ID: 11030057
[TBL] [Abstract][Full Text] [Related]
19. A developing country perspective on vaccine-associated paralytic poliomyelitis.
John TJ
Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
[TBL] [Abstract][Full Text] [Related]
20. [The perspective of global eradication of poliomyelitis].
Knolle H; Egli A; Candrian U
Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]